Cutaneous squamous cell carcinoma: from pathophysiology to novel therapeutic approaches L Fania, D Didona, FR Di Pietro, S Verkhovskaia, R Morese, G Paolino, ... Biomedicines 9 (2), 171, 2021 | 186 | 2021 |
Basal cell carcinoma: from pathophysiology to novel therapeutic approaches L Fania, D Didona, R Morese, I Campana, V Coco, FR Di Pietro, F Ricci, ... Biomedicines 8 (11), 449, 2020 | 142 | 2020 |
Bullous pemphigoid: trigger and predisposing factors F Moro, L Fania, JLM Sinagra, A Salemme, G Di Zenzo Biomolecules 10 (10), 1432, 2020 | 140 | 2020 |
Evidence for a ‘window of opportunity’in hidradenitis suppurativa treated with adalimumab: a retrospective, real‐life multicentre cohort study AV Marzano, G Genovese, G Casazza, C Moltrasio, P Dapavo, G Micali, ... British Journal of Dermatology 184 (1), 133-140, 2021 | 133 | 2021 |
Delayed melanoma diagnosis in the COVID‐19 era: increased breslow thickness in primary melanomas seen after the COVID‐19 lockdown. F Ricci, L Fania, A Paradisi, G Di Lella, S Pallotta, L Sobrino, ... Journal of the European Academy of Dermatology & Venereology 34 (12), 2020 | 100 | 2020 |
Role of nicotinamide in genomic stability and skin cancer chemoprevention L Fania, C Mazzanti, E Campione, E Candi, D Abeni, E Dellambra International journal of molecular sciences 20 (23), 5946, 2019 | 88 | 2019 |
Calculation of cut‐off values based on the Autoimmune Bullous Skin Disorder Intensity Score (ABSIS) and Pemphigus Disease Area Index (PDAI) pemphigus scoring systems for … C Boulard, S Duvert Lehembre, C Picard‐Dahan, JS Kern, G Zambruno, ... British Journal of Dermatology 175 (1), 142-149, 2016 | 76 | 2016 |
Multiple roles for cytokines in atopic dermatitis: from pathogenic mediators to endotype-specific biomarkers to therapeutic targets L Fania, G Moretta, F Antonelli, E Scala, D Abeni, C Albanesi, S Madonna International Journal of Molecular Sciences 23 (5), 2684, 2022 | 69 | 2022 |
Paraneoplastic dermatoses: a brief general review and an extensive analysis of paraneoplastic pemphigus and paraneoplastic dermatomyositis D Didona, L Fania, B Didona, R Eming, M Hertl, G Di Zenzo International Journal of Molecular Sciences 21 (6), 2178, 2020 | 67 | 2020 |
Large international validation of ABSIS and PDAI pemphigus severity scores V Hebert, C Boulard, E Houivet, SD Lehembre, L Borradori, R Della Torre, ... Journal of investigative dermatology 139 (1), 31-37, 2019 | 66 | 2019 |
IgE recognition of bullous pemphigoid (BP) 180 and BP230 in BP patients and elderly individuals with pruritic dermatoses L Fania, G Caldarola, R Müller, O Brandt, R Pellicano, C Feliciani, M Hertl Clinical Immunology 143 (3), 236-245, 2012 | 52 | 2012 |
Effectiveness of Secukinumab in the treatment of moderate–severe hidradenitis suppurativa: results from an Italian multicentric retrospective study in a real‐life setting. S Ribero, A Ramondetta, G Fabbrocini, V Bettoli, C Potenza, A Chiricozzi, ... Journal of the European Academy of Dermatology & Venereology 35 (7), 2021 | 43 | 2021 |
Detection and characterization of IgG, IgE, and IgA autoantibodies in patients with bullous pemphigoid associated with dipeptidyl peptidase-4 inhibitors L Fania, A Salemme, A Provini, G Pagnanelli, MC Collina, D Abeni, ... Journal of the American Academy of Dermatology 78 (3), 592-595, 2018 | 41 | 2018 |
Paradoxical psoriasis induced by TNF‐α blockade shows immunological features typical of the early phase of psoriasis development L Fania, M Morelli, C Scarponi, L Mercurio, F Scopelliti, C Cattani, ... The Journal of Pathology: Clinical Research 6 (1), 55-68, 2020 | 36 | 2020 |
Sex‐and gender‐associated clinical and psychosocial characteristics of patients with psoriasis M Napolitano, S Mastroeni, L Fania, S Pallotta, R Fusari, C Uras, ... Clinical and Experimental Dermatology 45 (6), 705-711, 2020 | 33 | 2020 |
Commentary on ‘Changing prevalence of diabetes mellitus in bullous pemphigoid: it is the dipeptidyl peptidase‐4 inhibitors’ L Fania, G Di Zenzo, C Mazzanti, D Abeni Journal of the European Academy of Dermatology and Venereology 32 (12), e439 …, 2018 | 30 | 2018 |
Ustekinumab treatment of pityriasis rubra pilaris: a report of five cases M Napolitano, L Lembo, L Fania, D Abeni, D Didona, B Didona The Journal of Dermatology 45 (2), 202-206, 2018 | 30 | 2018 |
A possible role for CD8+ T lymphocytes in the cell‐mediated pathogenesis of pemphigus vulgaris F Giurdanella, L Fania, M Gnarra, P Toto, D Di Rollo, DN Sauder, ... Mediators of Inflammation 2013 (1), 764290, 2013 | 29 | 2013 |
Merkel cell carcinoma E Dellambra, ML Carbone, F Ricci, F Ricci, FR Di Pietro, G Moretta, ... Biomedicines 9 (7), 718, 2021 | 27 | 2021 |
Bullous pemphigoid: Italian guidelines adapted from the EDF/EADV guidelines. E Cozzani, AV Marzano, M Caproni, C Feliciani, P Calzavara-Pinton Giornale Italiano di Dermatologia e Venereologia: Organo Ufficiale, Societa …, 2018 | 27 | 2018 |